Methi in Gestational Diabetes: Is It Safe in Pregnancy?

Gestational diabetes mellitus (GDM) is glucose intolerance first recognized during pregnancy and is associated with increased maternal and neonatal risks when glycemic control is inadequate. Management includes individualized nutrition therapy, physical activity, glucose monitoring, and pharmacological treatment when indicated. Methi (Trigonella foenum-graecum L.), commonly known as fenugreek, is traditionally used in food and herbal preparations and has attracted interest because of its potential glucose-lowering effects. However, evidence of benefit in nonpregnant adults with diabetes does not establish safety or efficacy during pregnancy. Clinicians should distinguish ordinary culinary use from concentrated supplements and medicinal preparations when counseling patients with GDM.^{1, 2, 3} 

Potential glucose-lowering effects of methi 

• Fenugreek seeds contain soluble fiber and bioactive compounds that may influence carbohydrate digestion, glucose absorption, and glucose regulation. 

• Reviews of clinical studies in people with type 2 diabetes have reported improvements in selected glycemic measures following fenugreek supplementation, but the evidence does not establish an effective or safe regimen for GDM.^{1, 2} 

• These findings cannot be directly extrapolated to pregnancy because the study populations, formulations, doses, and clinical circumstances differ. 

• No established clinical evidence supports using fenugreek supplements as a substitute for recommended GDM management or as a proven method of preventing pregnancy complications. 

Safety considerations during pregnancy 

• The National Center for Complementary and Integrative Health advises that fenugreek is not considered safe during pregnancy in amounts greater than those commonly found in food because its use has been associated with potential risks, including birth defects.³ 

• Safety data for concentrated fenugreek supplements and medicinal preparations during human pregnancy are insufficient to establish a safe dose or duration. 

• Fenugreek may lower blood glucose, creating a potential for additive glucose-lowering effects when used with insulin or other glucose-lowering medications. 

• Gastrointestinal symptoms and allergic reactions are recognized adverse effects, while the composition and concentration of commercial herbal products may vary. 

• Patients should disclose herbal supplements to their obstetric and diabetes care teams, particularly when taking medications or managing glucose levels closely. 

Clinical management of gestational diabetes 

• Nutrition counseling should focus on an individualized eating plan that supports appropriate maternal nutrition and glycemic targets without unnecessary dietary restriction. 

• Regular physical activity should be encouraged when medically appropriate and consistent with obstetric advice. 

• Self-monitoring of blood glucose should guide assessment of treatment response and help identify when additional intervention is needed. 

• When glucose targets are not achieved with lifestyle measures, pharmacological treatment should be selected according to established clinical guidance and individual maternal and fetal considerations. 

• Fenugreek should not delay evidence-based treatment, and patients should not reduce or discontinue prescribed medication in favor of herbal products. 

Practical counseling considerations 

Conclusion 

Methi has potential glucose-lowering effects in studies involving nonpregnant adults, but its role in gestational diabetes remains unestablished. Concentrated supplements and medicinal preparations should be avoided during pregnancy because safety has not been demonstrated and potential risks have been reported. Clinicians should prioritize evidence-based GDM management, review herbal product use, and provide balanced counseling that distinguishes customary culinary use from medicinal supplementation. 

References 

1. Sarker DK, Ray P, Dutta AK, Rouf R, Uddin SJ. Antidiabetic potential of fenugreek (Trigonella foenum-graecum): A magic herb for diabetes mellitus. Food Sci Nutr. 2024;12(10):7108-7136. doi:10.1002/fsn3.4440. https://pmc.ncbi.nlm.nih.gov/articles/PMC11521722/ 

2. Vajdi M, Noshadi N, Bonyadian A, et al. Therapeutic effect of fenugreek supplementation on type 2 diabetes mellitus: A systematic review and meta-analysis of clinical trials. Heliyon. 2024;10(17). doi:10.1016/j.heliyon.2024.e36649. https://pmc.ncbi.nlm.nih.gov/articles/PMC11403534/ 

3. National Center for Complementary and Integrative Health. Fenugreek: Usefulness and safety. Accessed October 27, 2026. https://www.nccih.nih.gov/health/fenugreek